Polaris AI Pharma Corp. (KOSDAQ:041910)

South Korea · Delayed Price · Currency is KRW

6,320.00

-50.00 (-0.78%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Manufacturing and Sales of Drug Substances	60.40B	61.32B	46.49B	40.34B	38.21B
Manufacturing and Sales of Drug Substances Growth	-1.51%	31.91%	15.26%	5.55%	-11.94%
Total	60.40B	61.32B	46.49B	40.34B	38.21B
Total Growth	-1.51%	31.91%	15.26%	5.55%	-11.94%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
South Korea	41.60B	34.18B	21.09B	17.67B	15.51B
South Korea Growth	21.70%	62.06%	19.38%	13.95%	-12.63%
Overseas	18.80B	27.14B	25.40B	22.67B	22.71B
Overseas Growth	-30.74%	6.87%	12.04%	-0.18%	-11.47%
Total	60.40B	61.32B	46.49B	40.34B	38.21B
Total Growth	-1.51%	31.91%	15.26%	5.55%	-11.94%

Source: S&P Global Market Intelligence.